JW Jungwo Pharmaceutical Fined 12.5 Billion KRW by National Tax Service
[Asia Economy Reporter Gong Byung-sun] JW Choongwae Pharmaceutical announced on the 25th that it was fined 12.5 billion KRW by the Seoul Regional Tax Office due to investigations on corporate tax and others conducted from 2016 to 2020.
Hot Picks Today
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
This amount corresponds to 6.01% of its equity capital.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.